Dioxins [polychlorinated dibenzo-p-dioxins (PCDD), dibenzofurans (PCDF)] and polychlorinated biphenyls (PCB) are potentially hazardous compounds. Animal studies have demonstrated that PCDD, PCDF, and PCB can alter thyroid hormone homeostasis. We investigated thyroid hormone levels in 105 mother-infant pairs. To estimate maternal and infant exposure, four nonplanar PCB congeners were measured in maternal plasma during the last month of pregnancy and in umbilical cord plasma. Seventeen PCDD and PCDF congeners, three planar PCB congeners, and 23 nonplanar PCB congeners were measured in human milk. Higher PCDD, PCDF, and PCB levels in human milk, expressed as toxic equivalents, correlated significantly with lower plasma levels of maternal total triiodothyronine and total thyroxine, and with higher plasma levels of TSH in the infants in the 2nd wk and 3rd mo after birth. Infants exposed to higher toxic equivalents levels had also lower plasma free thyroxine and total thy-PCDD and PCDF, summarized as dioxins, are tricyclic aromatic compounds. Because the number of chlorine atoms can vary between one and eight, there are potentially 75 different PCDD and 135 PCDF congeners. They are mainly formed as by-products during the synthesis of organochlorine chemicals and during the combustion of municipal and hazardous waste (1). PCB are a compilation of 209 possible congeners with different chlorine substitutions. Because of their unique physical properties and chemical stability, mixtures were used for diverse
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Both dioxins and PCB are highly lipophilic and chemically stable compounds that accumulate in the food chain. The higher chlorinated congeners are more abundant in most biotic samples. For human beings the main sources of environmental exposure to these toxic compounds are dairy products, meat, and fish. They are stored mainly in the human adipose tissue, with elimination half-lives of 6 to 10 y (5) . Small amounts of dioxins and PCB can reach the fetus by means of transplacental transport (6), whereas much higher levels reach the breast-fed infant. Dioxin levels can be especially high (IS100 pg TEQIg milk fat) in human milk samples from highly industrialized, densely populated countries such as the Netherlands, Belgium, the United Kingdom, and Germany (7) .
PCDD, PCDF, and PCB produce a wide spectrum of toxic effects in animals including body weight loss, immunotoxicity, thymic atrophy, hepatotoxicity, teratogenicity, carcinogenicity, and reproductive toxicity (8, 9) . Furthermore, they can alter thyroid hormone status in laboratory animals. In rats and monkeys, exposure to PCDD, PCDF, or PCB generally results in decreased plasma T, levels, accompanied by increased concentrations of TSH (10) (11) (12) (13) . There is evidence that human exposure to these compounds may result in altered thyroid hormone status as well. Reduced serum T4 levels have been observed in transformer repair workers exposed to PCB (14) . A recent study in a small group of breast-fed infants suggests that elevated levels of PCDD and PCDF in human milk might be associated with increases in plasma ?T, and TSH levels (15).
The aim of this study was to evaluate the effects of PCDD, PCDF, and PCB on the thyroid hormone status of pregnant women and their infants. This study is part of the Dutch PCBIDioxin Study, a larger prospective longitudinal study on possible adverse health effects of these pollutants on human beings.
METHODS
The study group consisted of 105 healthy mother-infant pairs recruited between June 1990 and February 1992, living in Rotterdam and the surrounding area, which is a highly industrialized region in The Netherlands. Women were asked by their obstetrician or midwife to volunteer for the study. During the last month of pregnancy, mothers were visited at home for an explanation of the study protocol. The obstetric, delivery, and neonatal conditions were assessed by means of the obstetrical optimality scale (16) . To establish an optimal study population, only infants born at term (37 to 42 wk of gestation) without congenital anomalies or diseases were included. All mother-infant pairs were of the Caucasian race. Pregnancy and delivery had to be completed without overt signs of serious illness or complications, and the infants had to be breast fed for at least 6 wk.
A blood sample was taken from the mothers in the last month of their pregnancy (36th to 40th wk) for the measurement of the PCB congeners 2,3',4,4',5-pentachlorobiphenyl (PCB 118), 2,2',3,4,4'.5'-hexachlorobiphenyl (PCB 138), 2,2',4,4',5,5'-hexachlorobiphenyl (PCB 153), and 2,2',3,4,4',5,5'-heptachlorobiphenyl (PCB 180) (17) . A blood sample of the umbilical cord was taken to measure the same PCB congeners as an indication of prenatal exposure. Blood was collected in a vacuum system EDTA tube, transported in a cooling pail, and centrifuged within 24 h during 15 min at 3000 rpm; plasma was stored at -20°C until analysis. The detection of PCDD and PCDF in human tissues and milk became possible only in 1984. Because large amounts of blood (100-200 mL) are still needed to measure PCDD and PCDF levels, we analyzed them in human milk samples. Because these levels in human milk correlate well with the dioxin levels in adipose tissue (18) , they are good indicators of maternal load and of prenatal and postnatal exposure of the breast-fed infant.
In the 2nd wk after delivery, the mothers collected a 24-h representative sample of breast milk by collecting before each feeding as much milk as possible from both breasts with a vacuum pump. An aliquot of 10% of each sample was pooled and stored in the refrigerator, the remainder was given to the infants in a bottle. After 24 h the milk was stored at -20°C until analysis.
PCB congeners in plasma were measured by GC with electron capture detection (19) . The human milk samples were analyzed for the 17 (17) were measured by GC with electron capture detection (21) .
To express the toxic potency of the mixture of dioxins and PCB in breast milk samples, the TEF approach was used (22, 23) . A TEFvalue was assigned to the dioxin and dioxin-like PCB congeners to represent their relative toxic potency toward 2,3,7,8-tetrachlorodibenzo-pdioxin, the most toxic dioxin congener, which has a TEF value of one. By multiplying the concentration (pglg milk fat) and TEF value, the TEQ of each congener was calculated (pg TEQ/g milk fat). By adding up the TEQ for all congeners, the total PCB-dioxin TEQ value was obtained. The TEQ sum of the dioxin and PCB congeners yielded a dioxin TEQ, planar-PCB TEQ (PCB 77, 126, and 169), and nonplanar-PCB TEQ (PCB 105, 118, 156, 170, and 180). The other PCB congeners did not receive a TEF value because they have negligible dioxin-like activity.
TI',, 'IT,, FT,, and TSH were measured in maternal plasma during the last month of pregnancy (maternal pregnancy), 9 to 14 d after delivery (maternal postdelivery), in plasma of the umbilical cord (umbilical cord plasma), and in infants' plasma 9 to 14 d (infant 2 wk) as well as 3 mo (infant 3 mo) after birth. 'IT3, ' IT.,, FT,, and TSH were determined by chemiluminescence immunoassay, using standard Amerlite assay kits (Amersham, England).
The study protocol was approved by the medical ethical committee of the University Hospital Rotterdam1 Sophia Children's Hospital. Informed consent was given by the parents.
Data analysis was performed by means of the statistical software package SPSSPC. Means, medians, ranges, and standard deviations are reported in terms of original distributions. Spearman rank correlation coefficients were measured between ' IT,, ' IT,, FT,, TSH levels and individual PCB and dioxin congener levels as well as dioxin TEQ, PCB TEQ, and total PCB-dioxin TEQ levels. Because of the large number of analyses, a p value < 0.01 was estimated as being statistically significant. The Mann-Whitney test was used to analyze the significance of differences in thyroid hormone status between a low and high exposed breast-fed group; a p value c 0.05 was estimated as being statistically significant.
RESULTS
Of the initial 105 mother-infant pairs, 78 fulfilled all criteria and were included in the analysis. The median and range of 'IT3, ' IT,, FT,, and TSH levels in maternal and infant plasma are summarized in Table 1 . One mother appeared to have an autoimmune hypothyroidism with high TSH levels. The levels of all the other mother-infant pairs were in the normal range for age-appropriate controls.
The The significant correlation coefficients between TEQ levels and thyroid hormone plasma levels are summarized in Table 2 . Higher levels of total PCB-dioxin TEQ, dioxin TEQ, and both planar-and nonplanar-PCB TEQ in human milk were significantly correlated with lower maternal plasma ' IT, levels in the last month of pregnancy and with lower maternal plasma 'IT3 and T I ' , levels in the 2nd wk after delivery. There was a trend toward a decline in the maternal plasma T I ' , level in the last month of pregnancy with higher planar-PCB TEQ levels (r = -0.27, p < 0.05). There were no significant correlations with maternal plasma R4 or TSH levels. The total PCBdioxin TEQ, dioxin TEQ, and PCB TEQ levels demonstrated no significant correlations with ' IT,, ' IT,, FT,, or TSH levels in umbilical cord plasma. However, higher TEQ levels were significantly correlated with higher plasma TSH levels in the infants in the 2nd wk and 3rd mo after birth.
Analyses of all individually measured PCDD, PCDF, and PCB congeners in human milk demonstrated that five PCDD congeners (2,3,7,8-tetrachlorodibenzo-p-dioxin,  1,2,3,7,8-pentachlorodibenzo-p-dioxin, 1,2,3,4,7,8-hexachlorodibenzo-p-dioxin, 1,2,3,6,7,8-hexachlorodibenzo-p-dioxin, and 1,2,3,7,8,9 -hexachlorodibenzo-pdioxin), three PCDF congeners (2,3,4,7,8-pentachlorodibenzofuran, 1,2,3,4,7,8-hexachlorodibenzofuran,  1,2,3,6,7,8-hexachlorodibenzofuran) , two planar PCB congeners (PCB 126 and 169), and 12 nonplanar PCB congeners (PCB 105, 118, 128, 138, 153, 156, 170, 177, 180, 183, 187, and 194) gave correlation coefficients with maternal or infants' thyroid hormone levels of the same order of magnitude as did the total PCB-dioxin TEQ, dioxin TEQ, and PCB TEQ levels. Higher levels of three nonplanar PCB congeners (PCB 137, 138, and 153) in human milk also correlated significantly with higher TSH levels in umbilical cord plasma (r = 0.31, p < 0.01). Higher levels of PCB 118, 138, 153, and 180 in maternal and cord plasma correlated significantly with higher plasma TSH levels in the infants in the 2nd wk after birth.
In Table 3 , the infants have been divided into a low [less than or equal to the median (30.75 pg TEQIg fat)] and a high (greater than the median) dioxin-exposed breast-fed group. The mean plasma T I ' , level was significantly lower, and the mean plasma TSH level was significantly higher in the high exposed group in the 2nd wk after birth. In umbilical cord plasma and at 3 mo, only the mean plasma TSH level was significantly higher in the high dioxin-exposed breast-fed group (8.5 6.0 versus 11.6 2 8.0 ~1 U l m L , p c 0.05,and 1.6 2 0.6vemus2.3 2 1.0 ~I u l m L , p c 0.0004). When the infants were divided into low and high total PCB-dioxin TEQ-exposed breastfed groups (median = 72.43 pg TEQIg fat), the mean plasma FT, level was also significantly lower in the high 
DISCUSSION
In this study, we found mean dioxin levels in human milk (32 pg TEQIg fat) that are elevated compared with the mean dioxin levels of countries in northern and southern Europe such as Sweden and Spain, which have levels of 20 and 13 pg TEQIg fat, respectively. The dioxin and PCB levels are comparable to the levels in other highly industrialized countries in western Europe, such as Belgium, the United Kingdom, and Germany (7) . Except for one mother with high TSH levels, plasma TT,, TT,, FT,, and TSH levels of all mother-infant pairs were in the normal range. We demonstrated that higher dioxin and PCB TEQ levels in human milk were significantly correlated with lower maternal plasma lT3 and TT4 levels and with higher infant plasma TSH levels in the 2nd wk and 3rd mo after birth. Twenty-two individual PCDD, PCDF, and PCB congener levels measured in human milk gave correlation coefficients with maternal and infant thyroid hormone levels of the same order of magnitude as did the TEQ levels. It is impossible from this study to define the dioxin or PCB congeners that really have an effect on thyroid hormone levels because there are associations between the congener patterns in humans (18) , who are exposed mainly to one source, food.
Reduced serum T4 levels have also been described in transformer repair workers exposed to PCB (14) . Murai et al. (24) described an increase in serum T3 and T4 levels in adults 16 y after exposure to high levels of PCB and PCDF via food compared with nonexposed controls. Serum FT,, TSH, and T, binding globulin levels were not altered. However, they did not find significant correlations between PCB levels and thyroid hormone levels in serum. The results might be different from our data because PCB were measured as total PCB level, which is less accurate compared with our congener-specific analysis. Furthermore, a short exposure to high PCB levels might have different effects on thyroid hormone parameters compared with a long-term background exposure. Pluim et al. (15) divided a group of 38 healthy newborns into a high and low dioxin-exposed breast-fed group compared with the median dioxin TEQ (29.0 pg TEQIg fat) in human milk. In agreement with our study, they found a significantly higher mean plasma TSH level 11 wk after birth in the high exposed group. In contrast to our study, they found significantly higher mean TT, levels in the infants' plasma at 1 and 11 wk after birth.
In general, the effects of dioxins and PCB in our human study resemble the effects on plasma TT3, TT,, IT4, and TSH levels in rats and monkeys (10) (11) (12) (13) 25) . In these animals, dioxins and PCB cause a reduction of plasma 'IT4 and FT4 levels and a concomitant increase in TSH levels. Plasma 'lT, levels are usually much less affected by dioxins and PCB. In rats, hydroxy-metabolites of PCB cause a decline in plasma 'IT4 levels. The metabolites have a marked structural resemblance to T4 and occupy the T4 binding pocket on TTR, the most important plasma binding protein for T, in rats (26) . In in vitro studies, hydroxy-metabolites of PCB and dioxins also compete with T4 for human TTR (27) . The binding capacity of T4 binding globulin, which is the most important binding protein for T4 in human plasma, does not seem to be influenced by PCB or dioxins (28) . Although the competition for binding to TI'R is unlikely to be the cause for a decreased plasma 'IT4 and TI; level in humans, it might still be of importance for T4 passage through the bloodbrain barrier. Herbert et al. (29) postulated that, also in humans, T4 transport from the circulation into the cere- brospinal fluid is based on the binding of T4 to TI'R produced in the choroid plexus. Hydroxy-metabolites of PCB, which can also be measured in human tissues (30) , could cause a decline in the local brain T4 level by interrupting the T4 transport on TI'R.
Besides affecting plasma thyroid hormone transport, dioxins and PCB can also alter peripheral T4 metabolism. In rats, dioxins and PCB decrease plasma TT4 levels by inducing hepatic uridine diphosphate-glucuronyltransferase. As a consequence, the biliary excretion of T4-glucuronide is enhanced (11, 31) . Morse et at. (32) demonstrated that decreases in plasma 'IT4 and FT, levels, induced by PCB, were accompanied by increases of type I1 T4 5'-deiodinase, the enzyme responsible for the deiodination of T4 to biologically active T3 in the brain of adult, fetal, and neonatal rats.
Small amounts of maternal thyroid hormone pass the placental barrier (33) and could be important for the early development of the fetus, which is able to produce its own thyroid hormones from the 12th wk on. Further research is necessary to elucidate the mechanism by which dioxins and PCB alter the thyroid hormone status in humans.
We did not find significant correlations between PCB levels in cord plasma or dioxin levels in human milk and lT3, TT,, FT,, or TSH levels in umbilical cord plasma.
However, when we related all individual PCB congener levels measured in human milk with the thyroid hormone levels in umbilical cord plasma, higher PCB 137, 138, and 153 congener levels correlated significantly with higher TSH levels in cord plasma. There are a few explanations for these differences in results. The PCB levels we measured in umbilical cord plasma were about 5 times lower compared with the levels in maternal plasma, about 20 times lower compared with PCB levels in human milk on volume base, and close to the detection limit. Secondly, the PCB levels in plasma were expressed on volume base and the dioxin and PCB levels in human milk on lipid base. Because dioxins and PCB are bound mainly to lipids, in which contents can vary, PCB levels in plasma expressed on lipid base might be more representative.
The higher plasma TSH levels in the 2nd wk and 3rd mo after birth may be a sustained reaction to prenatal exposure to dioxins and PCB to remain euthyroid. An alternative explanation for these increases in TSH levels is additional postnatal exposure to dioxins and PCB through breast feeding. When neonatal plasma TT,, TT4, FT4, and TSH levels were divided into low and high dioxin-exposed breast-fed groups, plasma TT4 was significantly lower and TSH significantly higher in the high exposed group in the 2nd wk after birth. When the thyroid hormone levels were divided into a low and high total PCB-dioxin TEQ-exposed breast-fed group, plasma FT,, was also significantly lower in the high exposed group. At the age of 3 mo, we found no significant differences in the infants' plasma 'IT3, lT4, or FT, levels, although TSH was still significantly higher. The infants' thyroid hormone production could have come into a new balance by TSH stimulation.
We demonstrated that Dutch levels of dioxins and PCB correlate with alterations of the human thyroid hormone status. Sufficient levels of T4, which is deiodinated into active T3 on the tissue level, are necessary for normal brain development (34) . Although the thyroid hormone levels were found to be in the normal range, the small changes observed in this study might be ofinfluence on the development of the fetus and infant; this will be the subject of further study.
